Enrique Granados, MD, Sh
About Enrique Granados, MD, Sh
Enrique Granados, MD, Sh, serves as the Senior Director of Clinical Research at Kite Pharma, where he has worked since 2018. With extensive experience in oncology and cell therapy, he has held various roles in prominent pharmaceutical companies and currently teaches at ESAME Pharmaceutical Business School.
Current Role at Kite Pharma
Enrique Granados serves as the Senior Director of Clinical Research at Kite Pharma since 2018. In this role, he focuses on advancing clinical research and development in the field of cell therapy. His work is centered in Madrid, Comunidad de Madrid, España, where he has contributed to the company's initiatives in innovative cancer treatments.
Previous Experience in Oncology
Before joining Kite Pharma, Granados held the position of Oncology Medical Manager at Merck Serono from 2009 to 2014 in Madrid, Spain. He also worked as Associate Director of Kite European Cell Therapy Medical Affairs at Gilead Sciences from 2014 to 2018 in Uxbridge, Greater London. His extensive experience in oncology has equipped him with a deep understanding of the medical landscape and patient needs.
Education and Expertise
Granados earned his Medical Doctor (M.D.) degree from Universidad Autónoma de Madrid, where he studied from 1987 to 1993. He also attended Santa María del Pilar from 1974 to 1987. His expertise lies in early clinical development, particularly in cell therapy for hematological conditions such as acute myeloblastic leukemia and solid tumors.
Teaching Role at ESAME Pharmaceutical Business School
In addition to his clinical research role, Granados has been a professor at ESAME Pharmaceutical Business School since 2022. He teaches a Master's program focused on the research and development of advanced therapies, contributing to the education of future professionals in the pharmaceutical industry.
Career in Medical Affairs
Granados has a background in medical affairs, having worked as a Medical Manager of New Products and Business Development at Wyeth Pharmaceuticals from 2002 to 2009. His responsibilities included providing support for medical inquiries from healthcare providers through various channels, enhancing communication between the company and the medical community.